Skip to main content
. 2020 Dec 23;16:3209–3224. doi: 10.2147/NDT.S289990

Figure 1.

Figure 1

Treatment with CH1 promotes long-term functional recovery after stroke. (A) Illustration of timeline for animal experiments. (B–E) Mice were subjected to dMCAO and i.p. injected with different concentrations (5 mg/kg, 10 mg/kg, 20 mg/kg) CH1 treatments. Sensorimotor functions were assessed before (baseline) and up to 28 days after dMCAO by the Rotarod (B), mNSS evaluation (C) and adhesive removal test (D and E). *P< 0.05, **P< 0.01 by one-way ANOVA or Kruskal–Wallis H-test, n = 10 mice per group.